神经生长因子在不同周龄小鼠睾丸组织中的表达

目的研究神经生长因子在小鼠不同周龄睾丸组织中的定量和定位表达。方法分别剖取不同周龄雄性小鼠的睾丸组织,部分提取总RNA,real-time PCR相对定量分析神经生长因子mRNA的表达量;另外部分组织固定、包埋,进行SABC法免疫组化分析,以观察神经生长因子蛋白在各周睾丸组织中的定位。结果Real-timePCR定量分析表明:小鼠生后1周龄睾丸组织有神经生长因子mRNA的表达,生后3周龄表达量达峰值,5周之后随鼠龄的增加呈下降趋势,成年小鼠睾丸组织的神经生长因子mRNA表达维持在一定水平。免疫组化定位分析显示:睾丸组织的神经生长因子蛋白表达于小鼠出生后的各个时期内,1周龄睾丸组织免疫阳性反应主要位于支持细胞,精原细胞也有着色;3周龄睾丸组织的间质细胞、各级生精细胞、支持细胞、管周肌样细胞表达均呈现阳性;5周后的睾丸组织内神经生长因子呈低水平表达,主要表达于间质细胞和生精细胞内。结论神经生长因子mRNA的表达量随着小鼠睾丸的生长发育期存在着一定的规律性变化;神经生长因子蛋白的表达在小鼠睾丸生长发育的不同时期其主要表达部位不同。     

LIM结构域蛋白KyoT在成年小鼠睾丸的表达

报道了KyoT在成年小鼠体内的表达,以便进一步研究KyoT在体内的功能。为研究KyoT mRNA及蛋白质水平的表达,采用Northern印迹、RT－PCR、免疫组织化学SABC和原位杂交方法。睾丸中两种KyoT的mRNA水平均很高,睾丸间质细胞的免疫化学反应阳性,阳性物质分布于细胞质内,细胞核呈阴性反应。同样,KyoT的mRNA在睾丸间质细胞杂交信号呈阳性反应,阳性物亦分布于细胞质内,细胞核呈阴性反应。生精细胞及对照组均为阴性。上述结果提示睾丸中有KyoT的表达,且特异性分布于睾丸间质细胞。     

PTIP相关蛋白1在小鼠睾丸发育过程中的表达及定位

目的探索PTIP相关蛋白1(PTIP associated protein 1,PA1)在小鼠睾丸发育过程中的表达定位。方法采用RTPCR、实时定量PCR和免疫组织化学方法,对PA1在小鼠睾丸不同发育阶段的表达及定位进行检测。结果 RT-PCR和实时定量PCR结果显示,PA1 m RNA在1w、2w、4w、8w、12w、18w和24w的小鼠睾丸中均有表达,且其表达量在2w时达到最高峰,在小鼠性成熟(8w)以后,PA1的表达量趋于平稳。ABC法免疫组织化学染色显示PA1在1w、2w、4w和8w小鼠睾丸各级生精细胞、支持细胞和间质细胞的胞核中均有表达,免疫荧光双标进一步确定PA1表达于支持细胞和间质细胞。结论 PA1可能在维持生精细胞的正常分化及调节睾丸内分泌的平衡中起重要作用。     

大鼠睾丸发育过程中促甲状腺激素释放激素受体mRNA的表达

为研究促甲状腺激素释放激素受体(TRHR)在大鼠睾丸组织中的表达规律和在生殖发育调节中的作用,依据大鼠垂体中的TRH-RcDNA设计引物,采用RT-PCR法从大鼠睾丸组织中获得了TRH-R的cDNA克隆,测序表明其核苷酸序列与大鼠垂体中的TRH-RcDNA序列完全一致.应用非放射性原位杂交(NR-ISH)技术观察TRH-RmRNA在大鼠睾丸中的定位,结果显示杂交信号集中在间质细胞中,生精细胞无杂交信号.利用实时动态定量RT-PCR法观察了TRH-R在不同发育阶段大鼠睾丸中的表达变化,发现在睾丸间质细胞发育的初期阶段(第8天),没有TRH-R的表达,但从第15天起能观察到TRH-R的表达,并且表达量在20天、35天、60天、90天逐渐增加.这些结果表明,大鼠睾丸组织间质细胞能特异性表达TRH-R,并且表达量与发育过程相关.     

神经型一氧化氮合酶在生后小鼠肾脏发育中的表达

目的观察生后小鼠肾脏发育不同阶段神经型一氧化氮合酶(nNOS)的表达,以及新生小鼠与成年小鼠肾脏nNOS表达差异,探讨nNOS在小鼠生后肾脏发育中的意义。方法分别取新生(出生小于2h)、生后3、5、7、14、40d昆明小鼠各8只,共6组。用免疫组织化学及免疫印迹方法对小鼠肾脏内nNOS表达进行定性、定量分析。结果新生小鼠生肾区nNOS呈强阳性表达,肾小管也有表达;成年小鼠肾远端小管,特别是致密斑,nNOS呈强阳性表达,集合管及肾小管均有阳性表达;新生小鼠肾脏nNOS含量最多,随后逐渐减少,成年小鼠nNOS含量最低。结论新生小鼠与成年小鼠肾脏nNOS表达部位不同,且表达含量由新生时最高到成年时降至最低。     

小鼠睾丸表皮生长因子受体及增殖细胞核抗原表达的加龄变化研究

观察了表皮生长因子受体及增殖细胞核抗原在生后１天至生后１０月龄昆明种小鼠睾丸内的表达,结果表明：精原细胞及初级精线产细胞从生后第２周至生后４周龄ＤＮＡ复制旺盛,增殖细胞核抗原免疫反应阳性细胞面密度于生后１４天出现峰值。生长因子受体在间质细胞、精母细胞内均有表达。生后４周时,精母细胞表皮生长因子受体表达较强,便于表皮生长因子发挥调节细胞增殖、调亡的作用。     

大鼠睾丸内皮型一氧化氮合酶表达的增龄变化

为研究雄性大鼠睾丸在发生、发育和衰老过程中内皮型一氧化氮合酶(eNOS)在生精功能中的作用及其变化规律，本实验采用了免疫组织化学染色及体视学图像分析等方法，对生后1d至生后24月龄大鼠睾丸eNOS表达的变化进行了系统研究，并统计测量了阳性血管内皮细胞及间质细胞面密度的变化。结果表明：生后1d至2周龄eNOS阳性表达极少；3周龄血管内皮细胞、间质细胞及精子细胞均出现了阳性表达；1月龄至18月龄生精小管靠近管腔的精子细胞也呈阳性，阳性血管内皮细胞、间质细胞数目差异显著；24月龄血管内皮细胞、间质细胞eNOS大量表达，部分生精细胞也有表达。本结果提示一氧化氮参与精子的生成及睾酮的分泌过程，衰老时eNOS阳性表达显著增加，这种变化可能会抑制睾酮的分泌，最终会影响睾丸的生精功能[动物学报49(3)：339—345，2003]。     

睾丸间质细胞在小鼠生精恢复过程中的作用

研究睾丸间质细胞对小鼠生精恢复过程的作用,可以为深入理解睾丸精原干细胞与其微环境(体)细胞间的相互关系提供实验证据。选取8周龄健康C57近交系成年雄性小鼠60只,腹腔注射22 mg/kg白消安建立小鼠精子发生受阻模型,随机分成1,2-二甲磺酸乙烷(ethane 1,2-dimethanesulphonate,EDS)处理组、氟他胺处理组和对照组,每组20只,3 d后分别给予EDS腹腔注射(100 mg/kg)、氟他胺埋植,对照组仅注射溶剂、埋植空管,分别在处理后的1个月内每周采样,Real-time RT-PCR检测CSF1、Gdnf、PLZF和Nanog m RNA表达水平,Gdnf蛋白水平表达,并在4周时进行睾丸组织HE染色,观察组织学变化并对相关指标进行量化分析。结果表明,小鼠睾丸间质细胞去除及雄激素受体阻断均能促进睾丸损伤后的生精恢复过程,但是,受体阻断的效果更强,说明间质细胞除了通过雄激素发挥作用外还直接对生精恢复起着一定的促进作用,这种促进作用可能是通过分泌CSF1等细胞因子来实现的。     

小鼠低剂量辐射损伤模型的初步研究

目的:对小鼠低剂量辐射损伤模型进行初步研究并筛选敏感检测指标.方法:实验分7组,1组为正常组,其余6组用XHA600直线加速器射线照射,每组取一部分小鼠于照射后2、4、8、16h测定红细胞(RBC)、白细胞(WBC)、血小板(PLT)和血红蛋白(HGB)含量;测定小鼠肝脏和脾脏重量及其组织中的超氧化合物歧化酶(SOD)和丙二醛(MDA)含量;剩余小鼠于4周后观察骨髓切片中血细胞变化.结果:照射后4h测定血常规,发现累积辐射0.4Gy组小鼠RBC有降低趋势,WBC、HGB显著降低,PLT显著升高;肝脏、脾脏的湿质量显著降低;小鼠肝脏组织中MDA的含量显著升高、SOD的活力显著降低;4周后小鼠骨髓细胞的病理改变与单次照射剂量相关,单次较大剂量(如0.6Gy)照射对骨髓细胞影响较大,在4周观察期不能自身恢复,而多次累积照射对骨髓细胞病理改变较小.结论:小鼠低剂量辐射损伤模型的最佳造模剂量为累积照射0.4Gy即每次照射100mGy,间隔一天,连续照射4次.     

链脲佐菌素糖尿病小鼠睾丸内生精细胞减少与PCNA和Ki67表达降低

目的通过检测增殖细胞核抗原(proliferating cell nuclear antigen,PCNA)及Ki67在正常及糖尿病小鼠睾丸组织中表达的差异,探讨糖尿病对生精细胞增殖的影响。方法 30只正常雄性C57BL/6小鼠,随机分为对照组(10只)和糖尿病组(20只)。采用腹腔注射链脲佐菌素的方法建立糖尿病小鼠模型,对照组注射相同体积的柠檬酸—柠檬酸钠缓冲液。造模成功3周后处死动物,取睾丸组织,常规固定、石蜡包埋、切片HE染色观察睾丸组织的形态学变化;免疫组织化学SP法检测PCNA及Ki67在睾丸组织中的表达;图像分析技术分析组织中PCNA及Ki67免疫组织化学表达水平。结果 HE染色显示,糖尿病小鼠睾丸内处于精子发生前半期的生精小管内生精细胞排列疏松,细胞层数偏少,附睾管内精子密度相对较低;免疫组织化学染色显示,PCNA和Ki67在糖尿病小鼠睾丸生精小管中的表达均明显降低。结论高糖可能通过降低生精细胞的增殖进而影响睾丸精子的发生。     

Cellular location and hormonal regulation of ghrelin expression in rat testis

Ghrelin, the endogenous ligand for the growth hormone-secretagogue receptor, is a recently cloned 28-amino acid peptide, expressed primarily in the stomach and hypothalamus, with the ability to stimulate growth hormone (GH) release and food intake. However, the possibility of additional, as yet unknown biological actions of ghrelin has been suggested. As a continuation of our recent findings on the expression and functional role of ghrelin in rat testis, we report here the pattern of cellular expression of ghrelin peptide in rat testis during postnatal development and after selective Leydig cell elimination, and we assess hormonal regulation of testicular ghrelin expression, at the mRNA and/or protein levels, in different experimental models. Immunohistochemical analyses along postnatal development demonstrated selective location of ghrelin peptide within rat testis in mature fetal- and adult-type Leydig cells. In good agreement, ghrelin protein appeared undetectable in testicular interstitium after selective Leydig cell withdrawal. In terms of hormonal regulation, testicular ghrelin mRNA and protein expression decreased to negligible levels after long-term hypophysectomy, whereas replacement with human chorionic gonadotropin (CG) (as superagonist of LH) partially restored ghrelin mRNA and peptide expression. Furthermore, acute administration of human CG (25 IU) to intact rats resulted in a transient increase in testicular ghrelin mRNA levels, with peak values 4 h after injection, an effect that was not mimicked by FSH (12.5 IU/rat). In contrast, testicular expression of ghrelin mRNA remained unaltered in GH-deficient rats, under hyper- and hypothyroidism conditions, as well as in adrenalectomized animals. In conclusion, our results demonstrate that mature Leydig cells are the source of ghrelin expression in rat testis, the protein being expressed in both fetal- and adult-type Leydig cells. In addition, our data indicate that testicular expression of ghrelin is hormonally regulated and is at least partially dependent on pituitary LH.     

Sertoli Cells Maintain Leydig Cell Number and Peritubular Myoid Cell Activity in the Adult Mouse Testis

The Sertoli cells are critical regulators of testis differentiation and development. In the adult, however, their known function is restricted largely to maintenance of spermatogenesis. To determine whether the Sertoli cells regulate other aspects of adult testis biology we have used a novel transgenic mouse model in which Amh-Cre induces expression of the receptor for Diphtheria toxin (iDTR) specifically within Sertoli cells. This causes controlled, cell-specific and acute ablation of the Sertoli cell population in the adult animal following Diphtheria toxin injection. Results show that Sertoli cell ablation leads to rapid loss of all germ cell populations. In addition, adult Leydig cell numbers decline by 75% with the remaining cells concentrated around the rete and in the sub-capsular region. In the absence of Sertoli cells, peritubular myoid cell activity is reduced but the cells retain an ability to exclude immune cells from the seminiferous tubules. These data demonstrate that, in addition to support of spermatogenesis, Sertoli cells are required in the adult testis both for retention of the normal adult Leydig cell population and for support of normal peritubular myoid cell function. This has implications for our understanding of male reproductive disorders and wider androgen-related conditions affecting male health.     

Immunoexpression of Tyro 3 family receptors--Tyro 3, Axl, and Mer--and their ligand Gas6 in postnatal developing mouse testis.

Tyro 3 family receptors contain three members-Tyro 3, Axl, and Mer-that are essential regulators of mammalian spermatogenesis. However, their exact expression patterns in testis are unclear. In this study, we examined the localizations of Tyro 3, Axl, Mer, and their ligand Gas6 in postnatal mouse testes by immunohistochemistry. All three members and their ligand were continuously expressed in different testicular cells during postnatal development. Tyro 3 was expressed only in Sertoli cells with a varied distribution during testis development. At day 3 postnatal, Tyro 3 was distributed in overall cytoplasmic membrane and cytoplasm of Sertoli cells. From day 14 to day 35 postnatal, Tyro 3 appeared on Sertoli cell processes toward the adlumenal compartment of seminiferous tubules. A stage-dependent Tyro 3 immunoexpression in Sertoli cells was shown by adulthood testis at day 56 postnatal with higher expression at stages I-VII and lower level at stages IX-XII. Axl showed a similar expression pattern to Tyro 3, except for some immunopositive Leydig cells detected in mature testis. In contrast, immunostaining of Mer was detected mainly in primitive spermatogonia and Leydig cells, whereas a relative weak signal was found in Sertoli cells. Gas6 was strongly expressed in Leydig cells, and a relative weak staining signal was seen in primitive spermatogonia and Sertoli cells. These immunoexpression patterns of Tyro 3 family receptors and ligand in testis provide a basis to further study their functions and mechanisms in regulating mammalian spermatogenesis.     

Effects and interactions of LH and LHRH agonist on testicular morphology and function in hypophysectomized rats

The effects of single or combined daily treatment with an LHRH agonist and low or high doses of LH upon the testes of adult hypophysectomized rats were studied for up to 2 weeks in which changes in testicular histology, particularly the interstitial tissue, were examined by morphometry and related to functional assessment of the Leydig cells in vivo and in vitro. Compared to saline-treated controls, LHRH agonist treatment did not alter testis volume or the composition of the seminiferous epithelium or any of the interstitial tissue components although serum testosterone and in-vitro testosterone production by isolated Leydig cells were significantly reduced. With 2 micrograms LH for treatment, testis volume was increased, spermatogenesis was qualitatively normal, total Leydig cell volume was increased, serum testosterone values were initially elevated but subsequently declined and in-vitro testosterone production was enhanced. Testis volume with 20 micrograms LH treatment was unchanged compared to saline treatment, the seminiferous epithelium exhibited severe disruption but total Leydig cell volume was greatly increased due to interstitial cell hyperplasia. This group showed elevated serum testosterone concentrations and major increases in testosterone production in vitro. Treatment with LHRH agonist with either dose of LH resulted in reduced testis volume, moderate to very severe focal spermatogenic disruption and increased total Leydig cell volume although serum testosterone values and in-vitro testosterone production were markedly reduced compared to control rats. It is concluded that, in the absence of the pituitary, LHRH agonist fails to disrupt spermatogenesis and the previously described antitesticular action of LHRH agonists in intact rats is therefore dependent upon the presence of LH, which alone or in combination with LHRH agonist, may focally disrupt spermatogenesis in hypophysectomized rats whereas the Leydig cells undergo hyperplasia. The findings show that impairment of spermatogenesis is accompanied by alterations of the interstitial tissue and suggest that communication between these two compartments is involved in the regulation of testicular function.     

HSL-knockout mouse testis exhibits class B scavenger receptor upregulation and disrupted lipid raft microdomains

There is a tight relationship between fertility and changes in cholesterol metabolism during spermatogenesis. In the testis, class B scavenger receptors (SR-B) SR-BI, SR-BII, and LIMP II mediate the selective uptake of cholesterol esters from HDL, which are hydrolyzed to unesterified cholesterol by hormone-sensitive lipase (HSL). HSL is critical because HSL knockout (KO) male mice are sterile. The aim of the present work was to determine the effects of the lack of HSL in testis on the expression of SR-B, lipid raft composition, and related cell signaling pathways. HSL-KO mouse testis presented altered spermatogenesis associated with decreased sperm counts, sperm motility, and infertility. In wild-type (WT) testis, HSL is expressed in elongated spermatids; SR-BI, in Leydig cells and spermatids; SR-BII, in spermatocytes and spermatids but not in Leydig cells; and LIMP II, in Sertoli and Leydig cells. HSL knockout male mice have increased expression of class B scavenger receptors, disrupted caveolin-1 localization in lipid raft plasma membrane microdomains, and activated phospho-ERK, phospho-AKT, and phospho-SRC in the testis, suggesting that class B scavenger receptors are involved in cholesterol ester uptake for steroidogenesis and spermatogenesis in the testis.     

Luteinizing hormone receptor-mediated effects on initiation of spermatogenesis in gonadotropin-deficient (hpg) mice are replicated by testosterone

Testosterone (T) is an absolute requirement for spermatogenesis and is supplied by mature Leydig cells stimulated by LH. We previously showed in gonadotropin-deficient hpg mice that T alone initiates qualitatively complete spermatogenesis bypassing LH-dependent Leydig cell maturation and steroidogenesis. However, because maximal T effects do not restore testis weight or germ cell number to wild-type control levels, additional Leydig cell factors may be involved. We therefore examined 1). whether chronic hCG administration to restore Leydig cell maturation and steroidogenesis can restore quantitatively normal spermatogenesis and testis development and 2). whether nonandrogenic Leydig cell products are required to initiate spermatogenesis. Weanling hpg mice were administered hCG (0.1-100 IU i.p. injection three times weekly) or T (1-cm subdermal Silastic implant) for 6 weeks, after which stereological estimates of germinal cell populations, serum and testicular T content, and testis weight were evaluated. Human CG stimulated Leydig cell maturation and normalized testicular T content compared with T treatment where Leydig cells remained immature and inactive. The maximal hCG-induced increases in testis weight and serum T concentrations were similar to those for T treatment and produced complete spermatogenesis characterized by mature, basally located Sertoli cells (SCs) with tripartite nucleoli, condensed haploid sperm, and lumen development. Compared with T treatment, hCG increased spermatogonial numbers, but both hCG and T had similar effects on numbers of spermatocytes and round and elongated spermatids per testis as well as per SC. Nevertheless, testis weight and germ cell numbers per testis and per SC remained well below phenotypically normal controls, confirming the involvement of non-Leydig cell factors such as FSH for quantitative normalization of spermatogenesis. We conclude that hCG stimulation of Leydig cell maturation and steroidogenesis is not required, and that T alone mostly replicates the effects of hCG, to initiate spermatogenesis. Because T is both necessary and sufficient for initiation of spermatogenesis, it is likely that T is the main Leydig cell secretory product involved and that additional LH-dependent Leydig cell factors are not essential for induction of murine spermatogenesis.     

SRG4在出生后小鼠睾丸及隐睾中的表达特性

研究小鼠生精新基因SRG4在出生后小鼠睾丸及手术隐睾中的表达特性, 为了解SRG4在精子发生中的作用奠定基础。取出生后1, 3, 12 w小鼠睾丸进行免疫组化检测, 观察SRG4蛋白在出生后小鼠不同发育阶段睾丸中的表达; 制备单侧手术隐睾模型, 取术后0~18 d 的隐睾组织进行半定量RT-PCR检测, 观察SRG4 mRNA在隐睾病变过程中的表达变化, 并对隐睾术后18 d 睾丸进行组织原位杂交分析。免疫组化分析结果表明, SRG4蛋白在出生1 w的小鼠睾丸中几乎检测不到, 在出生3 w的小鼠睾丸中有明显表达, 在出生12 w的小鼠中大量表达, 主要分布在精母细胞和圆形精子细胞胞浆及胞膜, 呈不均匀分布。半定量RT-PCR结果发现, SRG4 mRNA在小鼠隐睾术后0~6 d表达没有明显下调, 9 d 开始表达下调, 第18 d表达最低。组织原位杂交结果表明, 术后18 d隐睾睾丸生殖细胞大量凋亡, 精曲小管中仅见到个别的SRG4阳性信号, 而对照则不受影响。上述结果说明, SRG4蛋白表达受小鼠生长发育调控; 隐睾模型中, 随着生殖细胞的大量凋亡, SRG4基因表达下调, 提示SRG4基因可作为一个精子发生特定阶段的分子标记用以研究精子发生过程。     

Expression of connexin 43 in human testis

In order to further characterize the Sertoli cell state of differentiation, we investigated the expression of connexin 43 (cx43) protein in the testis of adult men both with normal spermatogenesis and associated with spermatogenic impairment, since cx43 is first expressed during puberty. Cx43 protein was found as a single 43-kDa band on western blots of extracts of normal human testicular material. Cx43 immunoreactivity was generally present between Leydig cells. Within the normal seminiferous epithelium cx43 immunoreactivity was localized between adjacent Sertoli cells, except at stages II and III of the seminiferous epithelial cycle when primary spermatocytes cross from the basal to the adluminal compartment suggesting a stage-dependent Sertoli cell function. While testes with hypospermatogenesis and spermatogenic arrest at the level of round spermatids or spermatocytes revealed a staining pattern similar to that of normal adult testis, the seminiferous tubules showing spermatogenic arrest at the level of spermatogonia and Sertoli-cell-only syndrome were completely immunonegative. We therefore assume that severe spermatogenic impairment is associated with a population of Sertoli cells exhibiting a stage of differentiation deficiency. Accepted: 10 June 1999     

p38 MAPK在小鼠睾丸不同发育阶段的表达和定位

为探讨丝裂原活化蛋白激酶p38 MAPK在小鼠睾丸不同发育阶段的表达，应用蛋白质免疫印迹杂交技术和免疫组织化学SABC法检测1至7周龄小鼠睾丸p38 MAPK的表达、定位及发育变化，并通过图像分析技术对免疫组织化学结果进行统计学分析。免疫印迹杂交发现，p38 MAPK在2～7周龄小鼠睾丸中均有表达。免疫组织化学结果显示，在2周龄小鼠睾丸曲细精管上皮中即可观察到p38 MAPK免疫阳性反应，免疫反应阳性细胞为精原细胞；3、4、5周龄小鼠睾丸仅有个别曲细精管上皮可见p38 MAPK免疫阳性反应；6、7周龄小鼠睾丸中p38 MAPK表达较丰富，免疫反应阳性细胞为精原细胞和初级精母细胞，免疫阳性反应物均主要位于细胞核内。在7周龄小鼠睾丸中还可见到部分间质细胞的细胞质亦呈p38 MAPK阳性。这些结果提示，p38 MAPK可能对生精细胞的增殖分化具有调控作用。     

A comparison of Leydig cell function after unilateral and bilateral cryptorchidism and efferent-duct-ligation

Surgical induction of cryptorchidism or ligation of the efferent ducts disrupts spermatogenesis. The response of Leydig cells to disrupted gametogenesis was studied in vitro in tissue and collagenase dispersed Leydig cells obtained from the testes of rats that were made unilaterally or bilaterally cryptorchid or had been efferent-duct-ligated. Four wks after surgery, androgen secretion per mg of tissue or per Leydig cell in response to maximal luteinizing hormone (LH) stimulation was greater in tissue from damaged than from sham-operated testes. It was concluded that disruption of spermatogenesis resulted in Leydig cells that were hyperresponsive to LH stimulation in vitro. Unilateral lesions produced different responsiveness of Leydig cells from the testes ipsilateral and contralateral to the lesion, supporting the hypothesis that intragonadal modulation of Leydig cells function occurs when the function of seminiferous tubules is impaired. Stimulated androgen production of Leydig cells from the contralateral nonligated testis did not differ from that of the sham-operated controls. With unilateral cryptorchidism, which is accompanied by an increase in the temperature of the operated testis, Leydig cells from the scrotal testis were also hyperresponsive compared to those from sham-operated controls. This suggests a possible intergonadal influence of aspermatogenesis caused by cryptorchidism.